Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Gossamer Bio, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 115 | 128 | +13 |
| Shares | 53.1M | 54.7M | +1.66M (+3.1%) |
| Value | $431.1M | $687.7M | +$256.7M (+59.5%) |
New holders (24)
Institutions that held Gossamer Bio, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (11)
Institutions that held Gossamer Bio, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Sio Capital Management, LLC | 261,400 | $2.12M |
| Farallon Capital Management, L.L.C. | 202,326 | $1.64M |
| Clough Capital Partners L P | 159,725 | $1.30M |
| Dowling & Yahnke LLC | 95,575 | $776.0K |
| Barclays PLC | 13,429 | $109.0K |
| Qube Research & Technologies Ltd | 13,271 | $108.0K |
| Squarepoint Ops LLC | 10,575 | $86.0K |
| SG3 Management, LLC | 2,000 | $16.0K |
| Cutler Group LP | 1,500 | $12.0K |
| Sandy Spring Bank | 300 | $2.00K |
| Advisory Services Network, LLC | 40 | $0 |